nodes	percent_of_prediction	percent_of_DWPC	metapath
Citalopram—SLC6A4—autistic disorder	0.636	1	CbGaD
Citalopram—SLC6A3—telencephalic ventricle—autistic disorder	0.00919	0.0709	CbGeAlD
Citalopram—HTR2C—telencephalic ventricle—autistic disorder	0.00888	0.0686	CbGeAlD
Citalopram—Escitalopram—SLC6A4—autistic disorder	0.00556	1	CrCbGaD
Citalopram—SLC6A3—hindbrain—autistic disorder	0.00434	0.0335	CbGeAlD
Citalopram—SLC6A4—hindbrain—autistic disorder	0.00397	0.0307	CbGeAlD
Citalopram—ADRA1A—hindbrain—autistic disorder	0.00325	0.0251	CbGeAlD
Citalopram—SLC6A3—brainstem—autistic disorder	0.00249	0.0192	CbGeAlD
Citalopram—HTR2C—brainstem—autistic disorder	0.0024	0.0186	CbGeAlD
Citalopram—SLC6A3—forebrain—autistic disorder	0.0024	0.0185	CbGeAlD
Citalopram—HTR2C—forebrain—autistic disorder	0.00232	0.0179	CbGeAlD
Citalopram—SLC6A4—brainstem—autistic disorder	0.00228	0.0176	CbGeAlD
Citalopram—SLC6A3—telencephalon—autistic disorder	0.00221	0.017	CbGeAlD
Citalopram—SLC6A4—forebrain—autistic disorder	0.0022	0.017	CbGeAlD
Citalopram—CHRM1—forebrain—autistic disorder	0.00219	0.0169	CbGeAlD
Citalopram—HTR2C—telencephalon—autistic disorder	0.00213	0.0165	CbGeAlD
Citalopram—SLC6A4—telencephalon—autistic disorder	0.00202	0.0156	CbGeAlD
Citalopram—CHRM1—telencephalon—autistic disorder	0.00201	0.0156	CbGeAlD
Citalopram—SLC6A2—brainstem—autistic disorder	0.00201	0.0155	CbGeAlD
Citalopram—SLC6A2—forebrain—autistic disorder	0.00194	0.0149	CbGeAlD
Citalopram—CYP2D6—hindbrain—autistic disorder	0.00192	0.0148	CbGeAlD
Citalopram—ADRA1A—brainstem—autistic disorder	0.00186	0.0144	CbGeAlD
Citalopram—ADRA1A—forebrain—autistic disorder	0.0018	0.0139	CbGeAlD
Citalopram—SLC6A2—telencephalon—autistic disorder	0.00178	0.0137	CbGeAlD
Citalopram—ADRA1A—telencephalon—autistic disorder	0.00165	0.0128	CbGeAlD
Citalopram—SLC6A4—digestive system—autistic disorder	0.00154	0.0119	CbGeAlD
Citalopram—HRH1—eye—autistic disorder	0.00141	0.0108	CbGeAlD
Citalopram—HRH1—forebrain—autistic disorder	0.00139	0.0108	CbGeAlD
Citalopram—SLC6A3—head—autistic disorder	0.00137	0.0106	CbGeAlD
Citalopram—HTR2C—head—autistic disorder	0.00133	0.0103	CbGeAlD
Citalopram—SLC6A3—nervous system—autistic disorder	0.0013	0.0101	CbGeAlD
Citalopram—HRH1—telencephalon—autistic disorder	0.00128	0.00989	CbGeAlD
Citalopram—CYP2C19—digestive system—autistic disorder	0.00128	0.00987	CbGeAlD
Citalopram—HTR2C—nervous system—autistic disorder	0.00126	0.00972	CbGeAlD
Citalopram—SLC6A4—head—autistic disorder	0.00126	0.00972	CbGeAlD
Citalopram—CHRM1—head—autistic disorder	0.00125	0.00968	CbGeAlD
Citalopram—SLC6A3—central nervous system—autistic disorder	0.00125	0.00968	CbGeAlD
Citalopram—CYP2E1—telencephalon—autistic disorder	0.00123	0.0095	CbGeAlD
Citalopram—SLC6A3—cerebellum—autistic disorder	0.00123	0.00946	CbGeAlD
Citalopram—HTR2C—central nervous system—autistic disorder	0.00121	0.00936	CbGeAlD
Citalopram—SLC6A4—nervous system—autistic disorder	0.00119	0.00922	CbGeAlD
Citalopram—CHRM1—nervous system—autistic disorder	0.00119	0.00918	CbGeAlD
Citalopram—SLC6A4—central nervous system—autistic disorder	0.00115	0.00887	CbGeAlD
Citalopram—CHRM1—central nervous system—autistic disorder	0.00114	0.00884	CbGeAlD
Citalopram—SLC6A2—head—autistic disorder	0.00111	0.00856	CbGeAlD
Citalopram—CYP2D6—brainstem—autistic disorder	0.0011	0.00848	CbGeAlD
Citalopram—CYP2D6—forebrain—autistic disorder	0.00106	0.00818	CbGeAlD
Citalopram—SLC6A2—nervous system—autistic disorder	0.00105	0.00811	CbGeAlD
Citalopram—CYP1A2—digestive system—autistic disorder	0.00104	0.00806	CbGeAlD
Citalopram—ADRA1A—head—autistic disorder	0.00103	0.00796	CbGeAlD
Citalopram—SLC6A2—central nervous system—autistic disorder	0.00101	0.00781	CbGeAlD
Citalopram—CYP2B6—digestive system—autistic disorder	0.001	0.00773	CbGeAlD
Citalopram—SLC6A3—brain—autistic disorder	0.000996	0.00769	CbGeAlD
Citalopram—HRH1—digestive system—autistic disorder	0.000978	0.00755	CbGeAlD
Citalopram—ADRA1A—nervous system—autistic disorder	0.000977	0.00754	CbGeAlD
Citalopram—CYP2D6—telencephalon—autistic disorder	0.000975	0.00753	CbGeAlD
Citalopram—HTR2C—brain—autistic disorder	0.000962	0.00743	CbGeAlD
Citalopram—ADRA1A—central nervous system—autistic disorder	0.000941	0.00726	CbGeAlD
Citalopram—CYP2E1—digestive system—autistic disorder	0.00094	0.00725	CbGeAlD
Citalopram—ADRA1A—cerebellum—autistic disorder	0.000919	0.0071	CbGeAlD
Citalopram—SLC6A4—brain—autistic disorder	0.000912	0.00704	CbGeAlD
Citalopram—CHRM1—brain—autistic disorder	0.000909	0.00702	CbGeAlD
Citalopram—CYP2B6—head—autistic disorder	0.000817	0.00631	CbGeAlD
Citalopram—SLC6A2—brain—autistic disorder	0.000803	0.0062	CbGeAlD
Citalopram—HRH1—head—autistic disorder	0.000798	0.00616	CbGeAlD
Citalopram—CYP2B6—nervous system—autistic disorder	0.000774	0.00598	CbGeAlD
Citalopram—CYP2E1—head—autistic disorder	0.000767	0.00592	CbGeAlD
Citalopram—ABCB1—forebrain—autistic disorder	0.000762	0.00589	CbGeAlD
Citalopram—HRH1—nervous system—autistic disorder	0.000756	0.00584	CbGeAlD
Citalopram—CYP3A4—digestive system—autistic disorder	0.000756	0.00584	CbGeAlD
Citalopram—ADRA1A—brain—autistic disorder	0.000747	0.00577	CbGeAlD
Citalopram—CYP2B6—central nervous system—autistic disorder	0.000746	0.00576	CbGeAlD
Citalopram—CYP2D6—digestive system—autistic disorder	0.000744	0.00574	CbGeAlD
Citalopram—HRH1—central nervous system—autistic disorder	0.000728	0.00562	CbGeAlD
Citalopram—CYP2E1—nervous system—autistic disorder	0.000727	0.00561	CbGeAlD
Citalopram—ABCB1—telencephalon—autistic disorder	0.000701	0.00541	CbGeAlD
Citalopram—CYP2E1—central nervous system—autistic disorder	0.0007	0.0054	CbGeAlD
Citalopram—CYP2E1—cerebellum—autistic disorder	0.000684	0.00528	CbGeAlD
Citalopram—CYP2D6—head—autistic disorder	0.000607	0.00469	CbGeAlD
Citalopram—CYP2B6—brain—autistic disorder	0.000592	0.00457	CbGeAlD
Citalopram—CYP3A4—nervous system—autistic disorder	0.000585	0.00451	CbGeAlD
Citalopram—HRH1—brain—autistic disorder	0.000578	0.00446	CbGeAlD
Citalopram—CYP2D6—nervous system—autistic disorder	0.000575	0.00444	CbGeAlD
Citalopram—CYP3A4—central nervous system—autistic disorder	0.000563	0.00435	CbGeAlD
Citalopram—CYP2E1—brain—autistic disorder	0.000555	0.00429	CbGeAlD
Citalopram—CYP2D6—central nervous system—autistic disorder	0.000554	0.00428	CbGeAlD
Citalopram—CYP2D6—cerebellum—autistic disorder	0.000541	0.00418	CbGeAlD
Citalopram—ABCB1—digestive system—autistic disorder	0.000535	0.00413	CbGeAlD
Citalopram—CYP2D6—brain—autistic disorder	0.00044	0.0034	CbGeAlD
Citalopram—ABCB1—head—autistic disorder	0.000437	0.00337	CbGeAlD
Citalopram—ABCB1—nervous system—autistic disorder	0.000414	0.0032	CbGeAlD
Citalopram—ABCB1—central nervous system—autistic disorder	0.000399	0.00308	CbGeAlD
Citalopram—ABCB1—cerebellum—autistic disorder	0.000389	0.00301	CbGeAlD
Citalopram—ABCB1—brain—autistic disorder	0.000316	0.00244	CbGeAlD
Citalopram—ADRA1A—Signaling by GPCR—PRKCB—autistic disorder	1.8e-05	7.9e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	1.8e-05	7.9e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—TPH2—autistic disorder	1.8e-05	7.86e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—CACNA1C—autistic disorder	1.79e-05	7.82e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—DPYD—autistic disorder	1.77e-05	7.74e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—PIK3CG—autistic disorder	1.76e-05	7.71e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—PIK3CG—autistic disorder	1.75e-05	7.68e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—RORA—autistic disorder	1.75e-05	7.65e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—CACNA1C—autistic disorder	1.74e-05	7.63e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—PIK3CG—autistic disorder	1.73e-05	7.56e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—AVP—autistic disorder	1.72e-05	7.53e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—POMC—autistic disorder	1.72e-05	7.52e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IGF2—autistic disorder	1.71e-05	7.49e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—CYP19A1—autistic disorder	1.68e-05	7.37e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—POMC—autistic disorder	1.68e-05	7.34e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PRL—autistic disorder	1.67e-05	7.32e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—POMC—autistic disorder	1.67e-05	7.31e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ADSL—autistic disorder	1.67e-05	7.3e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PRL—autistic disorder	1.67e-05	7.3e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—CYP19A1—autistic disorder	1.65e-05	7.22e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—POMC—autistic disorder	1.64e-05	7.2e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—CACNA1C—autistic disorder	1.64e-05	7.19e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PRL—autistic disorder	1.64e-05	7.18e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—MAOB—autistic disorder	1.64e-05	7.17e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—XDH—autistic disorder	1.63e-05	7.16e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—DHFR—autistic disorder	1.62e-05	7.11e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—PLA2G4A—autistic disorder	1.62e-05	7.08e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—STX1A—autistic disorder	1.6e-05	7.02e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—NPAS2—autistic disorder	1.6e-05	7.02e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—DHFR—autistic disorder	1.59e-05	6.94e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—ADRB2—autistic disorder	1.59e-05	6.94e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—ADRB2—autistic disorder	1.58e-05	6.92e-05	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—IL2—autistic disorder	1.57e-05	6.89e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—MEF2C—autistic disorder	1.57e-05	6.89e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—COMT—autistic disorder	1.57e-05	6.86e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—GSTP1—autistic disorder	1.56e-05	6.82e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—APOE—autistic disorder	1.56e-05	6.82e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—ADRB2—autistic disorder	1.56e-05	6.81e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—MAOA—autistic disorder	1.55e-05	6.81e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—TCN2—autistic disorder	1.55e-05	6.78e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—COMT—autistic disorder	1.53e-05	6.71e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—ITGB3—autistic disorder	1.53e-05	6.71e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—GSTP1—autistic disorder	1.53e-05	6.68e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—MAOA—autistic disorder	1.52e-05	6.67e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—TPH2—autistic disorder	1.52e-05	6.66e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—CAT—autistic disorder	1.52e-05	6.64e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—DPYD—autistic disorder	1.5e-05	6.55e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—DHFR—autistic disorder	1.49e-05	6.54e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—AVP—autistic disorder	1.49e-05	6.52e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—CAT—autistic disorder	1.48e-05	6.5e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—AVP—autistic disorder	1.48e-05	6.5e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IGF2—autistic disorder	1.48e-05	6.49e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IGF2—autistic disorder	1.48e-05	6.47e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ADA—autistic disorder	1.48e-05	6.47e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—AVP—autistic disorder	1.46e-05	6.4e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IGF2—autistic disorder	1.46e-05	6.37e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PLA2G4A—autistic disorder	1.43e-05	6.27e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—GSTM1—autistic disorder	1.43e-05	6.27e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—HTR2A—autistic disorder	1.43e-05	6.26e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—IL2—autistic disorder	1.43e-05	6.26e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	1.41e-05	6.16e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PLA2G4A—autistic disorder	1.4e-05	6.14e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—GSTM1—autistic disorder	1.4e-05	6.14e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PLA2G4A—autistic disorder	1.4e-05	6.13e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PLA2G4A—autistic disorder	1.4e-05	6.11e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CACNA1C—autistic disorder	1.39e-05	6.09e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PLA2G4A—autistic disorder	1.37e-05	6.02e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—GPX1—autistic disorder	1.37e-05	6e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	1.37e-05	6e-05	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—IL2—autistic disorder	1.36e-05	5.97e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—MEF2C—autistic disorder	1.36e-05	5.97e-05	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—IL2—autistic disorder	1.36e-05	5.95e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—TSC2—autistic disorder	1.36e-05	5.95e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—MEF2C—autistic disorder	1.36e-05	5.95e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—RORA—autistic disorder	1.35e-05	5.9e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—GPX1—autistic disorder	1.34e-05	5.88e-05	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—IL2—autistic disorder	1.34e-05	5.86e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—POMC—autistic disorder	1.34e-05	5.86e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—MEF2C—autistic disorder	1.34e-05	5.85e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—LEP—autistic disorder	1.33e-05	5.82e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—APOE—autistic disorder	1.33e-05	5.82e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—ITGB3—autistic disorder	1.33e-05	5.81e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—ITGB3—autistic disorder	1.32e-05	5.8e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—ITGB3—autistic disorder	1.3e-05	5.71e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—CYP19A1—autistic disorder	1.27e-05	5.57e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—DHFR—autistic disorder	1.27e-05	5.54e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—MTHFR—autistic disorder	1.27e-05	5.54e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—MAOB—autistic disorder	1.26e-05	5.53e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—PRKCB—autistic disorder	1.25e-05	5.49e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—CYP19A1—autistic disorder	1.24e-05	5.44e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—HTR2A—autistic disorder	1.24e-05	5.43e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—MTHFR—autistic disorder	1.24e-05	5.43e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—IL2—autistic disorder	1.24e-05	5.43e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—HTR2A—autistic disorder	1.24e-05	5.41e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—IL2—autistic disorder	1.23e-05	5.41e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—HTR2A—autistic disorder	1.22e-05	5.33e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—IL2—autistic disorder	1.22e-05	5.32e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—APC—autistic disorder	1.2e-05	5.26e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—PIK3CG—autistic disorder	1.2e-05	5.26e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.19e-05	5.23e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—EGF—autistic disorder	1.19e-05	5.2e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—COMT—autistic disorder	1.18e-05	5.18e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—APOE—autistic disorder	1.18e-05	5.16e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TSC2—autistic disorder	1.18e-05	5.16e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—GSTP1—autistic disorder	1.18e-05	5.16e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—MAOA—autistic disorder	1.17e-05	5.14e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—TPH2—autistic disorder	1.17e-05	5.14e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TSC2—autistic disorder	1.17e-05	5.14e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—CYP19A1—autistic disorder	1.17e-05	5.12e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TSC2—autistic disorder	1.16e-05	5.06e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—DPYD—autistic disorder	1.16e-05	5.06e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—COMT—autistic disorder	1.15e-05	5.06e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—APOE—autistic disorder	1.15e-05	5.05e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—APOE—autistic disorder	1.15e-05	5.05e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—LEP—autistic disorder	1.15e-05	5.05e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—GSTP1—autistic disorder	1.15e-05	5.03e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—APOE—autistic disorder	1.15e-05	5.03e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—LEP—autistic disorder	1.15e-05	5.03e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—MAOA—autistic disorder	1.15e-05	5.02e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—CAT—autistic disorder	1.15e-05	5.02e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—POMC—autistic disorder	1.14e-05	5e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—LEP—autistic disorder	1.13e-05	4.95e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—APOE—autistic disorder	1.13e-05	4.95e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—CAT—autistic disorder	1.12e-05	4.9e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IGF1—autistic disorder	1.1e-05	4.81e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—MAPK1—autistic disorder	1.09e-05	4.79e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—COMT—autistic disorder	1.09e-05	4.76e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PRKCB—autistic disorder	1.09e-05	4.76e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PRKCB—autistic disorder	1.08e-05	4.74e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GSTP1—autistic disorder	1.08e-05	4.74e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—GSTM1—autistic disorder	1.08e-05	4.74e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PLA2G4A—autistic disorder	1.08e-05	4.74e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—MAOA—autistic disorder	1.08e-05	4.73e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CACNA1C—autistic disorder	1.07e-05	4.7e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	1.07e-05	4.67e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PRKCB—autistic disorder	1.07e-05	4.67e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PIK3CG—autistic disorder	1.06e-05	4.66e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—GSTM1—autistic disorder	1.06e-05	4.62e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PLA2G4A—autistic disorder	1.06e-05	4.62e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—CAT—autistic disorder	1.05e-05	4.61e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—SERPINE1—autistic disorder	1.04e-05	4.57e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PIK3CG—autistic disorder	1.04e-05	4.56e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—APC—autistic disorder	1.04e-05	4.55e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PIK3CG—autistic disorder	1.04e-05	4.55e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—APC—autistic disorder	1.04e-05	4.54e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PIK3CG—autistic disorder	1.04e-05	4.54e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—GPX1—autistic disorder	1.04e-05	4.54e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—EGF—autistic disorder	1.03e-05	4.5e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—EGF—autistic disorder	1.02e-05	4.49e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—APC—autistic disorder	1.02e-05	4.47e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PIK3CG—autistic disorder	1.02e-05	4.47e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—POMC—autistic disorder	1.01e-05	4.43e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—GPX1—autistic disorder	1.01e-05	4.43e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—EGF—autistic disorder	1.01e-05	4.42e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GSTM1—autistic disorder	9.95e-06	4.36e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PLA2G4A—autistic disorder	9.95e-06	4.36e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CYP19A1—autistic disorder	9.91e-06	4.34e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—POMC—autistic disorder	9.91e-06	4.34e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—POMC—autistic disorder	9.9e-06	4.33e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—POMC—autistic disorder	9.87e-06	4.32e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—DHFR—autistic disorder	9.77e-06	4.28e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—POMC—autistic disorder	9.71e-06	4.25e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—MTHFR—autistic disorder	9.56e-06	4.19e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GPX1—autistic disorder	9.53e-06	4.17e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IGF1—autistic disorder	9.52e-06	4.17e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IGF1—autistic disorder	9.49e-06	4.16e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—MAPK1—autistic disorder	9.48e-06	4.15e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—MAPK1—autistic disorder	9.45e-06	4.14e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IGF1—autistic disorder	9.34e-06	4.09e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—MTHFR—autistic disorder	9.33e-06	4.09e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	9.31e-06	4.08e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—MAPK1—autistic disorder	9.3e-06	4.07e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—COMT—autistic disorder	9.22e-06	4.04e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GSTP1—autistic disorder	9.17e-06	4.02e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—MAOA—autistic disorder	9.15e-06	4.01e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—SERPINE1—autistic disorder	9.04e-06	3.96e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—SERPINE1—autistic disorder	9.01e-06	3.95e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CAT—autistic disorder	8.93e-06	3.91e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—APOE—autistic disorder	8.9e-06	3.9e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—SERPINE1—autistic disorder	8.87e-06	3.89e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—MTHFR—autistic disorder	8.79e-06	3.85e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—HRAS—autistic disorder	8.78e-06	3.84e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—APOE—autistic disorder	8.69e-06	3.8e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IL2—autistic disorder	8.45e-06	3.7e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GSTM1—autistic disorder	8.43e-06	3.69e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PLA2G4A—autistic disorder	8.43e-06	3.69e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—IL6—autistic disorder	8.4e-06	3.68e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—APOE—autistic disorder	8.19e-06	3.59e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GPX1—autistic disorder	8.07e-06	3.54e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PTGS2—autistic disorder	8.07e-06	3.53e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PIK3CG—autistic disorder	8.03e-06	3.52e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—PTEN—autistic disorder	7.95e-06	3.48e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PTGS2—autistic disorder	7.91e-06	3.46e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PIK3CG—autistic disorder	7.84e-06	3.43e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CYP19A1—autistic disorder	7.65e-06	3.35e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—POMC—autistic disorder	7.65e-06	3.35e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—HRAS—autistic disorder	7.61e-06	3.33e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—HRAS—autistic disorder	7.58e-06	3.32e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—HRAS—autistic disorder	7.46e-06	3.27e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—POMC—autistic disorder	7.46e-06	3.27e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—MTHFR—autistic disorder	7.45e-06	3.26e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PIK3CG—autistic disorder	7.39e-06	3.24e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IL2—autistic disorder	7.32e-06	3.2e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IL2—autistic disorder	7.29e-06	3.19e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—IL6—autistic disorder	7.28e-06	3.19e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—IL6—autistic disorder	7.26e-06	3.18e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IL2—autistic disorder	7.18e-06	3.14e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—IL6—autistic disorder	7.14e-06	3.13e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—COMT—autistic disorder	7.11e-06	3.12e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GSTP1—autistic disorder	7.08e-06	3.1e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—MAOA—autistic disorder	7.06e-06	3.09e-05	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PTEN—autistic disorder	7.04e-06	3.08e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—POMC—autistic disorder	7.03e-06	3.08e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—APOE—autistic disorder	6.94e-06	3.04e-05	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PTEN—autistic disorder	6.89e-06	3.02e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CAT—autistic disorder	6.89e-06	3.02e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PTEN—autistic disorder	6.89e-06	3.02e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PTEN—autistic disorder	6.86e-06	3.01e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PTEN—autistic disorder	6.76e-06	2.96e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PLA2G4A—autistic disorder	6.51e-06	2.85e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GSTM1—autistic disorder	6.51e-06	2.85e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—MAPK1—autistic disorder	6.46e-06	2.83e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PIK3CG—autistic disorder	6.26e-06	2.74e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GPX1—autistic disorder	6.23e-06	2.73e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PTGS2—autistic disorder	6.1e-06	2.67e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—POMC—autistic disorder	5.96e-06	2.61e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PTGS2—autistic disorder	5.95e-06	2.61e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—MTHFR—autistic disorder	5.75e-06	2.52e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PTGS2—autistic disorder	5.61e-06	2.46e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—MAPK1—autistic disorder	5.6e-06	2.45e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—MAPK1—autistic disorder	5.58e-06	2.44e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—MAPK1—autistic disorder	5.49e-06	2.41e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—APOE—autistic disorder	5.35e-06	2.34e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PTEN—autistic disorder	5.32e-06	2.33e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PTEN—autistic disorder	5.19e-06	2.27e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—HRAS—autistic disorder	5.19e-06	2.27e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IL6—autistic disorder	4.96e-06	2.17e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PTEN—autistic disorder	4.89e-06	2.14e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PIK3CG—autistic disorder	4.83e-06	2.12e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PTGS2—autistic disorder	4.75e-06	2.08e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—POMC—autistic disorder	4.6e-06	2.01e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—HRAS—autistic disorder	4.49e-06	1.97e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—HRAS—autistic disorder	4.48e-06	1.96e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—HRAS—autistic disorder	4.41e-06	1.93e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IL6—autistic disorder	4.3e-06	1.88e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IL6—autistic disorder	4.29e-06	1.88e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IL6—autistic disorder	4.22e-06	1.85e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PTEN—autistic disorder	4.14e-06	1.81e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PTGS2—autistic disorder	3.67e-06	1.61e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PTEN—autistic disorder	3.2e-06	1.4e-05	CbGpPWpGaD
